Business Wire

Auto Shanghai 2023 ushers in a new era of intelligent vehicles! Nearly 20 mass-produced models equipped with RoboSense LiDAR

Share

RoboSense, a world-leading provider of Smart LiDAR Sensor Systems, announced today its M series LiDAR products, which assisted more than 10 well-known global automakers showcase nearly 20 intelligent vehicle models at the 20th Shanghai International Automobile Industry Exhibition 2023 (referred to as the Auto Shanghai 2023), presenting the excellent performance of their intelligent driving assistance systems to the audience.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230428005133/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Part of EV models equipped with RoboSense LiDAR showcased at Auto Shanghai 2023 (Photo: Business Wire)

This year's Shanghai Auto Show brought more than 1,000 exhibitors, including well-known global car companies, independent domestic car brands, new car-making forces, and automobile technology companies, using 13 indoor exhibition halls.

The M series sensors were the first LiDAR in the world to achieve automotive-grade mass production. It uses a patented revolutionary chip-based 2D scanning solution that boasts supreme performance and reliability.

According to the statistics obtained by industry media, “there are 38 models equipped with LiDARs at Auto Shanghai 2023, of which RoboSense is the biggest winner, being the LiDAR supplier of 18 of them”,the brands including SAIC IM, BYD, XPeng, FAW Hongqi, GWM WEY, Chery Exeed, Geely, GAC Hyper, Lotus, etc. To date, RoboSense has earned design wins for mass production of LiDAR products for over 50 vehicle models with 18 automakers.

As the theme of this auto show, "Embracing the New Era of the Automobile Industry," the global automobile industry is accelerating its transformation and upgrading towards electrification and intelligence. Against this backdrop, this year's Shanghai Auto Show is not only a concentrated display of product strength for the global automobile industry's intelligent transformation and upgrading, but also strong evidence of RoboSense's efforts to accelerate the intelligent development of the automobile industry.

RoboSense has invested heavily in building world-class product development and testing capabilities, while expanding its global footprint with operational headquarters in both Europe and the US. Its capabilities include intelligent manufacturing system in Southern China, along with the world’s first and only certified accreditation automotive-grade LiDAR laboratory, its China National Accreditation Service (CNAS) certified LiDAR lab, with more than 200 advanced pieces of testing equipment.

RoboSense's M series LiDAR technology has played a significant role in the intelligent transformation of the automobile industry, and the 2023 Shanghai Auto Show has demonstrated the excellent performance of intelligent driving assistance systems, showcasing the industry's progress towards electrification and intelligence.

About RoboSense (www.robosense.ai):

RoboSense (Suteng Innovation Technology Co., Ltd.) is a world-leading provider of Smart LiDAR Sensor Systems. Comprising LiDAR sensors, AI algorithms and IC chipsets, its portfolio transforms conventional 3D LiDAR sensors with comprehensive data analysis and interpretation systems.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Grace Ye
media@robosense.ai

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct

Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release

Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we

Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release

AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by

illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release

illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont

Textron Aviation Broadens Aftermarket Connectivity Solutions for Cessna Citation Latitude by Offering Starlink High-Speed Internet18.9.2025 16:30:00 EEST | Press release

Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced an additional high-speed internet connectivity solution for the Cessna Citation Latitude following the Federal Aviation Administration’s (FAA) issuance of AeroMech’s Supplemental Type Certificate (STC) for Starlink high-speed internet connectivity. AeroMech’s STC utilizes Starlink’s constellation of Low Earth Orbit (LEO) satellites to provide more reliable connectivity over land, water and remote areas, where traditional in-flight Wi-Fi may not have service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918380069/en/ Textron Aviation broadens aftermarket connectivity solutions for Cessna Citation Latitude by offering Starlink high-speed internet (Photo Credit: Textron Aviation) “With Starlink connectivity now available as an upgrade, Citation Latitude customers can enjoy a seamless, high-speed in-flight experience that keeps them connected in more

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye